Hydration Room, a Southern California-based chain of IV and injection therapy clinics, opened a new location in Los Gatos as ...

On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Injectafer (ferric carboxymaltose) is a prescription drug that’s used to treat iron deficiency anemia. Injectafer comes as a liquid solution for intravenous (IV) injection or infusion. It’s always ...

A research team has developed an intravenous (IV) needle that softens upon insertion, minimizing risk of damage to blood vessels and tissues. Once used, it remains soft even at room temperature, ...

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. The Food and Drug Administration (FDA) approval of ...

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...

Amgen (NASDAQ: AMGN) today announced positive topline results from a Phase 3 trial of TEPEZZA (teprotumumab-trbw) administered by subcutaneous injection via an on-body injector (OBI) in participants ...

Intravenous (IV) injection is a method commonly used in patient’s treatment worldwide as it induces rapid effects and allows treatment through continuous administration of medication by directly ...